Benchmarking only delivers strategic value when it’s intentional and contextual, without clearly defined objectives, the right peer group, and an understanding of what metrics truly mean, organizations risk drawing misleading conclusions and wasting valuable time and resources. Done wrong, generic or one-off reports can skew decisions; done right, continuously updated and customized benchmarks become a powerful engine for informed decision-making and competitive advantage.
Competitive intelligence has become a strategic necessity in life sciences as pipelines grow more complex and competition accelerates. This article explores how CI teams are evolving to deliver earlier, more actionable insights that support high-stakes decision-making.
Continuous benchmarking replaces static, annual comparisons with ongoing performance tracking, helping organizations identify risks earlier and make more informed, timely strategic decisions.
Artificial intelligence is increasingly shaping life sciences competitive intelligence, but most organizations are still early in practical adoption. Sedulo Group’s research shows that while many CI teams see efficiency gains from AI, few have fully embedded it into standardized, decision-ready workflows.
The 2025 Life Sciences CI Survey Report reveals how CI functions are evolving, highlighting structural trends, the strategic value organizations place on early threat detection, and the growing yet measured role of AI in shaping competitive insight and decision-making across the industry.
Benchmarking doesn’t have to be overwhelming. This guide breaks down a simple, repeatable process to benchmark anything, from pricing to performance, so you can generate insights that actually move strategy forward.
Turning insights into impact often comes down to one powerful slide, the “gold.” Learn how to craft a single, executive-ready slide that leads with the answer, sharpens your key insights, and transforms research findings into a clear business mandate.
In an era of mounting uncertainty, the Probability and Impact Matrix empowers teams to move beyond gut instinct and align on where risks and opportunities deserve real attention. By plotting potential scenarios across likelihood and consequence, organizations unlock clarity in prioritization, and drive smarter, more focused strategic decisions.
The Sedulo Confidence Rating Scale gives your team a clear, common language to assess how much trust to put in intelligence, reducing ambiguity and bias. Use this 1-to-4 scale (plus Public and Analysis tiers) to prioritize insights, focus effort, and support stronger decisions.
Bringing a new therapy to market is one of the riskiest bets in pharma, nearly one in three launches falls short of expectations, while 60% underperform when multiple therapies compete in the same space. Competitive intelligence (CI) isn’t just a tactical tool, when integrated early and continuously across development, it guides trial design, shapes payer strategy, and equips commercial teams to pivot ahead of competitive threats.
